Skip to Content

View Additional Section Content

NRG-BR004 A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer (NRG-BR004)

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03199885?term=br004&rank=2

Clinical Trial Categories

  • Breast Cancer
Contact
Carolann Twelves, RN at 215-481-4149

Location

  • Asplundh Cancer Pavilion
    3941 Commerce Ave.
    Willow Grove, PA 19090

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926